Soleus Capital Management, L.P.
Top Portfolio Positions
76 positions ·
$1,851,234,357 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
|
941,059 | $232,008,685 | 12.53% |
| CELC |
Celcuity Inc.
|
1,808,258 | $180,355,652 | 9.74% |
| PRAX |
Praxis Precision Medicines, Inc.
|
362,966 | $106,980,598 | 5.78% |
| TGTX |
Tg Therapeutics, Inc.
|
3,139,312 | $93,582,890 | 5.06% |
| DXCM |
Dexcom Inc
|
1,297,094 | $86,088,128 | 4.65% |
| BMRN |
Biomarin Pharmaceutical Inc
|
1,320,000 | $78,447,600 | 4.24% |
| BBNX |
Beta Bionics, Inc.
|
2,534,565 | $77,228,195 | 4.17% |
| TWST |
Twist Bioscience Corp
|
1,861,802 | $59,056,359 | 3.19% |
| ORGO |
Organogenesis Holdings Inc.
|
9,985,951 | $51,727,226 | 2.79% |
| SNDX |
Syndax Pharmaceuticals Inc
|
2,247,110 | $47,211,781 | 2.55% |
Portfolio Trend
Holdings in NRIX
Export CSVShares Held
Position Value (USD)
15 of 15 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $23,131,904 | 1,219,394 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,386,976 | 2,422,833 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,596,067 | 2,422,833 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $28,783,256 | 2,422,833 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $39,617,373 | 2,102,833 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,949,289 | 1,065,834 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,906,966 | 2,055,916 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,390,500 | 1,115,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,475,760 | 143,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,398,040 | 814,000 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $6,568,996 | 504,144 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,600,213 | 994,492 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,173,048 | 1,011,638 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,516,740 | 743,238 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,906,444 | 263,900 | Shares | Sole | 2021-11-15 | |
| No quarters match your search. | ||||||